Green tea catechins sit at the centre of Japan’s Foods with Function Claims and Specified Health Use (Tokuho/FOSHU) markets for body fat, so brands abroad ask for a Japan-made catechin product almost by reflex. The reputation is real, but it comes from a specific regulatory pathway, not from a single settled verdict in the wider research.
This guide separates what an independent Cochrane review found on weight, what Japanese regulators have accepted for body fat claims, and a liver-safety limit the European Union now enforces at high catechin doses. All three facts matter for how you word a label and how you set an amount per serving.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a green tea catechin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
An independent Cochrane review found that green tea preparations produce a small, statistically non-significant weight loss that is unlikely to be clinically important, and could not pool the Japanese trials because they differed too much, while a Japanese randomised trial using a high-catechin green tea extract reported reductions in body fat.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Cochrane systematic review, Cochrane Database of Systematic Reviews 2012 (doi 10.1002/14651858.CD008650.pub2) | Randomised controlled trials of at least 12 weeks on green tea preparations for weight loss and weight maintenance in overweight or obese adults; trials were split into those run in Japan and those run elsewhere because of heterogeneity | Six trials outside Japan (532 participants) pooled to a weight difference of −0.04 kg, not significant; the eight trials in Japan (1,030 participants) were not similar enough to pool, with differences ranging from −0.2 to −3.5 kg in favour of green tea; overall, a small, statistically non-significant weight loss not likely to be clinically important; evidence on weight maintenance was limited |
| Randomised, double-blind controlled trial, Obesity 2007 (PMID 17557985, doi 10.1038/oby.2007.176) | Japanese adults with visceral fat-type obesity, keeping their usual diet and activity, given green tea with 583 mg catechins/day or a low-catechin control tea (96 mg/day) for 12 weeks; 240 analysed | Continuous ingestion of the high-catechin extract was associated with reductions in body fat, systolic blood pressure and LDL cholesterol compared with the low-catechin tea |
The Cochrane review could pool only the trials run outside Japan; the Japanese trials, which reported larger differences, varied too much to combine, so their range is not a single pooled estimate. Adverse events in the review were mostly mild to moderate. The 2007 trial was run in Japanese adults with visceral fat-type obesity, all its authors worked at a food manufacturer’s research laboratories, and it used a specific high-catechin extract and dose against a low-catechin comparator tea, not a placebo without any catechins, and it measured body fat rather than body weight alone — a different, narrower endpoint than the Cochrane review’s primary outcome. Results from one catechin dose and population do not automatically transfer to another.
Checked against the published abstracts on 12 October 2026.
What Japanese products say
Japan’s Specified Health Use Foods (Tokuho) and Foods with Function Claims systems have long accepted catechin products with wording about body fat, aimed at people who are concerned about their body fat level.
Government-reviewed Tokuho catechin products typically carry wording to the effect that the product is rich in tea catechins, helps the body use fat as an energy source, and suits people who are concerned about their body fat — not a claim of weight loss or fat “reduction” as a medical outcome. Each Tokuho product is reviewed and approved individually by Japanese authorities on its own evidence package; a catechin ingredient itself is not blanket-approved for every formulation or dose.
Two points matter for a brand abroad:
- The Tokuho wording is about body fat as a everyday concern, not disease. It never claims to treat obesity or any medical condition.
- A Tokuho or Foods with Function Claims notification is a Japanese regulatory mechanism for products sold in Japan. It does not transfer to your label in another market.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent reviews? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe catechins by what has been studied and at what amount, not by a promise of weight loss.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains green tea catechins” with the EGCG or total catechin amount per serving | ”Burns fat” or “guarantees weight loss" |
| "Studied in relation to body fat at [x] mg/day” | Names of obesity or any medical condition |
| ”A source of catechins, as used in some Japanese food formulations" | "Clinically proven” without naming the study, its dose and its limits |
How green tea catechins are formulated
Catechins are polyphenols extracted from green tea leaf, dosed in milligrams, and the ceiling that matters most is a European Union limit on high-dose EGCG, not a Japanese one.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or hard capsule | Precise dosing, flavourless | Standard choice for higher-EGCG formulas |
| Powder stick or sachet | Mixed into drinks, familiar Japanese format | Bitterness at higher catechin content |
| Ready-to-drink tea or beverage | Matches the Tokuho beverage category in Japan | Lower catechin concentration per serving than a tablet |
Decisions that shape the specification:
- Source and standardisation. Green tea extract is standardised to a total catechin or EGCG content; ask the supplier for the certificate of analysis on both figures, since EGCG is usually the dominant and most-studied catechin.
- Amount per serving, checked against your market’s EGCG limit. The European Food Safety Authority’s 2018 opinion found that EGCG intakes of 800 mg/day or more from food supplements may raise the likelihood of liver injury (doi 10.2903/j.efsa.2018.5239), and the EU’s Regulation (EU) 2022/2340 now requires that a food supplement’s daily portion stay below 800 mg of EGCG, with a mandatory warning on any pack that could reach that level. Confirm the equivalent limit, if any, in every market you plan to sell in — Japan has not set the same numeric cap for green tea catechins as a food ingredient.
- Caffeine content. Green tea extract carries natural caffeine unless decaffeinated; state the caffeine content on the specification separately from the catechin content.
- Companion ingredients. Catechins are often combined with other metabolism-themed ingredients; each companion needs its own check against Japanese food law.
- Packaging and stability. Catechins oxidise on exposure to light, heat and moisture; opaque, moisture-proof packaging protects potency through shelf life.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Green tea catechin extract itself is well established in Japanese foods, so the ingredient itself is rarely the obstacle. The EGCG dose and the companion ingredients in a “weight and metabolism” formula are where a specification most often needs adjusting for a specific export market. See the Japan-made supplement OEM page, and compare with our MCT oil and dietary fibre guides for two more weight-and-metabolism ingredients.
Before you ask for a quotation
A factory can quote accurately once the catechin and EGCG content, the form, the companions and the packaging are fixed.
- Total catechin content and EGCG content per serving, checked against your market’s limits
- Caffeine content, natural or reduced
- Dosage form and packaging
- Companion ingredients and their amounts
- Countries you will sell in, and each market’s EGCG or catechin limit
- First order and annual volume
💬 Ready to design a Japan-made green tea catechin product? Send us the concept — catechin amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does green tea catechin cause weight loss?
An independent Cochrane review found only a small, statistically non-significant weight loss from green tea preparations, unlikely to be clinically important. Trials run in Japan reported larger differences but varied too much to be pooled. Describe the ingredient as studied for body weight and body fat, not as a weight-loss guarantee.
2. Why do Japanese products still make body-fat claims then?
Japan’s Tokuho and Foods with Function Claims systems approve individual products on their own submitted evidence, often using a specific high-catechin extract and dose. That is a Japanese regulatory mechanism tied to a specific product, not a blanket endorsement of catechins in general.
3. Is there a maximum safe amount of EGCG?
The European Food Safety Authority’s 2018 opinion linked EGCG intakes of 800 mg/day or more from supplements to a higher likelihood of liver injury, and EU Regulation (EU) 2022/2340 now caps supplement portions below that level with a mandatory warning. Confirm the limit for each market you sell in.
4. Which dosage form suits green tea catechins best?
Tablets and hard capsules give the most precise dosing, especially for higher-EGCG formulas. Powder sticks and ready-to-drink formats work at lower catechin concentrations, closer to a brewed tea.
5. What can stop a Japanese factory making my catechin product?
Usually the EGCG dose against your target market’s limit, or a companion ingredient in a metabolism formula. Every ingredient and amount must be permitted in foods in the country of sale, so we check the full formula first.
Sources: “Green tea for weight loss and weight maintenance in overweight or obese adults”, Cochrane Database of Systematic Reviews 2012, doi 10.1002/14651858.CD008650.pub2; “A Green Tea Extract High in Catechins Reduces Body Fat and Cardiovascular Risks in Humans”, Obesity 2007, PMID 17557985, doi 10.1038/oby.2007.176; “Scientific Opinion on the safety of green tea catechins”, EFSA Journal 2018, doi 10.2903/j.efsa.2018.5239; Commission Regulation (EU) 2022/2340 amending Annex III to Regulation (EC) No 1925/2006 as regards green tea extracts containing EGCG; Japan Consumer Affairs Agency, Specified Health Use Foods and Foods with Function Claims notifications. Checked on 12 October 2026.